Dive into the world of biosimilars with leading Canadian healthcare experts! This panel discussion explores the evolution of biosimilar adoption, patient access challenges, healthcare stakeholder perspectives, and the future of innovative medical treatments. Learn about cost savings, patient support programs, and how Canada is becoming a global leader in biosimilar implementation. Featuring insights from top professionals in pharmaceutical policy, healthcare administration, and industry strategy.

Key Topics:
– Biosimilar transition experiences across Canadian provinces
– Patient and caregiver access challenges
– Healthcare system adaptation
– Cost sustainability and national pharmacare
– Future of biologics and biosimilars

Featuring: Tijana Fazlagic of BC Ministry of Health, Jody Cox of Biosimilars Canada, Alan Lawless of Mantioba Health and moderated by Michael Sine of TEVA Canada.

#BiosimilarsinCanada #HealthcareSavings #InnovativeMedicine #PatientAccess #PrecisionHealthcare